Typhilitis symptoms and treatment
Reading File
Searching for typhlitis symptoms and treatment in parallel.
search_medical_text
typhlitis symptoms clinical presentation neutropenic enterocolitis
Harrison's Principles of Internal Medicine, Twenty First Edition
Page 2194
search_medical_text
typhlitis treatment management neutropenic enterocolitis
Bailey and Love's Short Practice of Surgery 28th Edition
Page 1363
GradeResponse
GradeResponse
Typhlitis (Neutropenic Enterocolitis)
Typhlitis — also called neutropenic colitis, necrotizing enteropathy, ileocecal syndrome, or cecitis — is a life-threatening inflammatory condition of the cecum (and sometimes the terminal ileum and ascending colon) occurring in immunocompromised patients.
Etiology & Risk Factors
- Classically follows cytotoxic chemotherapy, especially in patients with AML or ALL (acute myeloid/lymphocytic leukemia)
- More common in children than adults
- Occurs in the setting of profound neutropenia
- Causative organisms include gram-negative bacteria and Clostridium septicum, which can cause rapidly progressive septicemia (Bailey & Love's, p. 1363)
Symptoms & Clinical Presentation
(Harrison's Principles of Internal Medicine, 21st ed., p. 2194)
| Feature | Details |
|---|---|
| Fever | Common presenting sign |
| Abdominal pain | Right lower quadrant (RLQ) tenderness; may be generalized |
| Rebound tenderness | Present in some cases |
| Diarrhea | Common; often bloody |
| RLQ mass | May be palpable on exam or seen on plain film |
Diagnosis
- CT scan with contrast or MRI: preferred — demonstrates thickened cecal wall (most sensitive)
- Ultrasonography: can also show cecal wall thickening
- Plain films: may show a RLQ mass but are far less sensitive than CT/MRI
Treatment
(Harrison's, p. 2194; Bailey & Love's, p. 1363)
1. Conservative (first-line in most cases):
- Broad-spectrum antibiotics covering gram-negative organisms and anaerobes (including Clostridium spp.)
- Haematopoietic growth factors (e.g., G-CSF) to support neutrophil recovery
- Bowel rest, IV fluids, nutritional support
2. Surgical intervention:
- Rarely indicated but may be attempted to prevent perforation from ischemia
- Reserved for cases with perforation, uncontrolled bleeding, or failure of medical management
Complications & Prognosis
- Bowel perforation (from ischemia/necrosis)
- Gram-negative or clostridial septicemia — can be rapidly fatal
- Mortality is significant, particularly if diagnosis is delayed or perforation occurs
Clinical pearl: Typhlitis should be suspected in any neutropenic oncology patient presenting with fever and RLQ pain. Prompt CT imaging and early antibiotic therapy are key to improving outcomes.
Which antibiotics should be preferred
search_medical_text
typhlitis neutropenic enterocolitis antibiotic regimen selection gram-negative anaerobic coverage
Harrison's Principles of Internal Medicine, Twenty First Edition
Page 3979
GradeResponse
search_medical_text
febrile neutropenia empirical antibiotic therapy piperacillin-tazobactam carbapenem cefepime
Harrison's Principles of Internal Medicine, Twenty First Edition
Page 2206
GradeResponse
Preferred Antibiotics for Typhlitis
Since typhlitis occurs in neutropenic patients, antibiotic selection follows febrile neutropenia guidelines with added emphasis on anaerobic coverage (given cecal/bowel involvement).
First-Line Empirical Regimens
The following monotherapy options have shown equal efficacy in large trials for febrile neutropenia with prolonged neutropenia (>7 days), and all cover Pseudomonas aeruginosa plus broad gram-negative and gram-positive spectra (Harrison's, p. 2206):
| Agent | Notes |
|---|---|
| Piperacillin/tazobactam | Preferred in many centers — broad-spectrum including anaerobes |
| Cefepime | Good gram-negative coverage; add metronidazole for anaerobic cover |
| Ceftazidime | Anti-pseudomonal; add metronidazole for anaerobic cover |
| Imipenem/cilastatin or Meropenem | Broad-spectrum including anaerobes; associated with higher C. difficile risk (imipenem) |
Anaerobic Coverage — Critical for Typhlitis
Unlike general febrile neutropenia, typhlitis involves the bowel, so anaerobic organisms (especially Clostridium septicum) must always be covered (Bailey & Love's, p. 1363; Harrison's, p. 3979):
- Piperacillin/tazobactam and carbapenems provide intrinsic anaerobic coverage
- If using cefepime or ceftazidime, add metronidazole to cover anaerobes
When to Escalate
- If the patient is hemodynamically unstable or has suspected resistant organisms → meropenem (preferred carbapenem due to lower C. difficile risk vs. imipenem)
- If gram-positive bacteremia is suspected (e.g., line infection) → add vancomycin
Duration
With adequate source control, antibiotics can typically be limited to 4–5 days, though in neutropenic patients, treatment is usually continued until neutrophil recovery (Harrison's, p. 3979).
Bottom line: Piperacillin/tazobactam is the most commonly preferred single agent for typhlitis — it covers gram-negatives (including Pseudomonas), gram-positives, and anaerobes. Carbapenems (meropenem) are the go-to for severe or refractory cases.
This is a shared conversation. Sign in to Orris to start your own chat.